161 related articles for article (PubMed ID: 37648382)
1. Metabolic control and incidence of hypoglycaemia, hospitalisation and complications among Saudi patients with type 2 diabetes initiating second-line therapy: an analysis of the Saudi Arabia data from the DISCOVER Observational Study programme.
Al Rubeaan K; Banah F; Alruwaily FG; Sheshah E; Alnaqeb D; AlQahtani AM; Ewais D; Al Juhani N; Hassan AH; Youssef AM
BMJ Open; 2023 Aug; 13(8):e063586. PubMed ID: 37648382
[TBL] [Abstract][Full Text] [Related]
2. Socioeconomic factors associated with hypoglycaemia in patients starting second-line glucose-lowering therapy: The DISCOVER study.
Rathmann W; Charbonnel B; Gomes MB; Hammar N; Khunti K; Kosiborod M; Kuss O; Shestakova MV; Watada H; Shimomura I; Tang F; Cid-Ruzafa J; Chen H; Fenici P; Surmont F; Ji L;
Diabetes Res Clin Pract; 2020 Jul; 165():108250. PubMed ID: 32531326
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal assessment of the quality of life and patterns of antidiabetic medication use in patients with type 2 diabetes, Saudi Arabia perspective, DISCOVER study.
Al-Rubeaan K; Banah F; Alruwaily FG; Sheshah E; Alnaqeb D; AlQahtani AM; Ewais D; Al Juhani N; Hassan AH; Youssef AM
Curr Med Res Opin; 2023 Jan; 39(1):27-35. PubMed ID: 36342972
[TBL] [Abstract][Full Text] [Related]
4. Associations of fear of hypoglycemia with second-line use of insulin secretagogues or insulin and subsequent glycemic control in patients with type 2 diabetes: An analysis using data from the DISCOVER study.
Wang JS; Chen H; Tang F; Sheu WH
Int J Clin Pract; 2020 Jun; 74(6):e13485. PubMed ID: 32003099
[TBL] [Abstract][Full Text] [Related]
5. Attitudes and perceptions towards hypoglycaemia in patients with diabetes mellitus: A multinational cross-sectional study.
Naser AY; Wong ICK; Whittlesea C; Alwafi H; Abuirmeileh A; Alsairafi ZK; Turkistani FM; Bokhari NS; Beykloo MY; Al-Taweel D; Almane MB; Wei L
PLoS One; 2019; 14(10):e0222275. PubMed ID: 31647820
[TBL] [Abstract][Full Text] [Related]
6. Self-reported Hypoglycaemic Events in 2 430 Patients with Insulin-treated Diabetes in the German Sub-population of the HAT Study.
Kern W; Holstein A; Moenninghoff C; Kienhöfer J; Riedl M; Kulzer B
Exp Clin Endocrinol Diabetes; 2017 Oct; 125(9):592-597. PubMed ID: 28750429
[TBL] [Abstract][Full Text] [Related]
7. Switching from Neutral Protamine Hagedorn Insulin to Insulin Glargine 300 U/mL Improves Glycaemic Control and Reduces Hypoglycaemia Risk: Results of a Multicentre, Prospective, Observational Study.
Wolnik B; Wiza D; Szczepanik T; Syta A; Klupa T
J Diabetes Res; 2020; 2020():8751348. PubMed ID: 32337298
[TBL] [Abstract][Full Text] [Related]
8. Does hypoglycaemia affect the improvement in QoL after the transition to insulin in people with type 2 diabetes?
Wieringa TH; de Wit M; Twisk JWR; Snoek FJ
J Endocrinol Invest; 2018 Feb; 41(2):249-258. PubMed ID: 28803366
[TBL] [Abstract][Full Text] [Related]
9. Comparable glycaemic control and hypoglycaemia in adults with type 2 diabetes after initiating insulin glargine 300 units/mL or insulin degludec: The DELIVER Naïve D real-world study.
Sullivan SD; Nicholls CJ; Gupta RA; Menon AA; Wu J; Westerbacka J; Bosnyak Z; Frias JP; Bailey TS
Diabetes Obes Metab; 2019 Sep; 21(9):2123-2132. PubMed ID: 31144445
[TBL] [Abstract][Full Text] [Related]
10. Hypoglycaemia in patients with type 2 diabetes treated with a combination of metformin and sulphonylurea therapy in France.
Vexiau P; Mavros P; Krishnarajah G; Lyu R; Yin D
Diabetes Obes Metab; 2008 Jun; 10 Suppl 1():16-24. PubMed ID: 18435670
[TBL] [Abstract][Full Text] [Related]
11. Vascular complications in patients with type 2 diabetes: prevalence and associated factors in 38 countries (the DISCOVER study program).
Kosiborod M; Gomes MB; Nicolucci A; Pocock S; Rathmann W; Shestakova MV; Watada H; Shimomura I; Chen H; Cid-Ruzafa J; Fenici P; Hammar N; Surmont F; Tang F; Khunti K;
Cardiovasc Diabetol; 2018 Nov; 17(1):150. PubMed ID: 30486889
[TBL] [Abstract][Full Text] [Related]
12. (Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus.
Semlitsch T; Engler J; Siebenhofer A; Jeitler K; Berghold A; Horvath K
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD005613. PubMed ID: 33166419
[TBL] [Abstract][Full Text] [Related]
13. Frequency and predictors of confirmed hypoglycaemia in type 1 and insulin-treated type 2 diabetes mellitus patients in a real-life setting: results from the DIALOG study.
Cariou B; Fontaine P; Eschwege E; Lièvre M; Gouet D; Huet D; Madani S; Lavigne S; Charbonnel B
Diabetes Metab; 2015 Apr; 41(2):116-25. PubMed ID: 25465273
[TBL] [Abstract][Full Text] [Related]
14. Quality of diabetes care, diabetes knowledge and risk of severe hypoglycaemia one and four years after participation in a 5-day structured treatment and teaching programme for intensified insulin therapy.
Schiel R; Ulbrich S; Müller UA
Diabetes Metab; 1998 Dec; 24(6):509-14. PubMed ID: 9932217
[TBL] [Abstract][Full Text] [Related]
15. Compliance with treatment and fear of hypoglycaemia in patients with type 2 diabetes.
Yuksel M; Bektas H
J Clin Nurs; 2021 Jun; 30(11-12):1773-1786. PubMed ID: 33660356
[TBL] [Abstract][Full Text] [Related]
16. The Real-Life Effectiveness and Care Patterns of Type 2 Diabetes Management in Greece.
Pagkalos E; Thanopoulou A; Sampanis C; Bousboulas S; Melidonis A; Tentolouris N; Alexandrides T; Migdalis I; Karamousouli E; Papanas N
Exp Clin Endocrinol Diabetes; 2018 Jan; 126(1):53-60. PubMed ID: 28704857
[TBL] [Abstract][Full Text] [Related]
17. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
18. Initiation of insulin glargine in patients with Type 2 diabetes in suboptimal glycaemic control positively impacts health-related quality of life. A prospective cohort study in primary care.
Hajos TR; Pouwer F; de Grooth R; Holleman F; Twisk JW; Diamant M; Snoek FJ
Diabet Med; 2011 Sep; 28(9):1096-102. PubMed ID: 21843305
[TBL] [Abstract][Full Text] [Related]
19. Hypoglycaemic episodes in patients with type 2 diabetes--risk factors and associations with patient-reported outcomes: The PANORAMA Study.
Simon D; de Pablos-Velasco P; Parhofer KG; Gönder-Frederick L; Duprat Lomon I; Vandenberghe H; Eschwège E; Bradley C
Diabetes Metab; 2015 Dec; 41(6):470-9. PubMed ID: 26455870
[TBL] [Abstract][Full Text] [Related]
20. Three-Year Glycaemic Control and Management in Patients with Type 2 Diabetes Initiating Second-Line Treatment in Japan: A Prospective Observational Study, J-DISCOVER.
Takahara M; Mita T; Katakami N; Wada F; Morita N; Kidani Y; Yajima T; Shimomura I; Watada H;
Diabetes Ther; 2022 Feb; 13(2):251-264. PubMed ID: 34962628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
